Red Maple Trials

Pre-Screening Study for Participants With Environmental Allergies (including birch) for Future Participation in Research Studies.

The objective of this pre-screening protocol is to pre-screen and confirm eligibility of participants with a documented history of moderate to severe environmental allergic rhinitis/rhinoconjunctivitis due to birch pollen exposure, for participation in clinical studies involving birch allergen-specific immunotherapy at Red Maple Trials.

Desentum_C1A05912_Pre-Screening — Red Maple Trials birch allergy, allergies

A Pre-Screening Study to Conduct a Future Clinical Study in Participants Allergic to Common Ragweed (Ambrosia artemisiifolia).
This pre-screening study will identify and characterize a patient population with a history of ragweed-induced rhinoconjunctivitis who may benefit from treatment and potentially be included in future interventional studies.
Please click on the link below if you are interested in the study:

RMT014 — Red Maple Trials A Pre-Screening Study to Conduct a Future Clinical Study in Participants Allergic to Common Ragweed (Ambrosia artemisiifolia)If you are interested in participating in this clinical trial, please fill out the contact form below to speak to one of our Research Coordinators to find out if this study is...